Funding sources This study was supported by a grants from the French Ministry of Health (PHRC IR 2006 Jalenques, No. 2008-A00343-52) and from Société Française de Dermatologie 2010.

^‡

Conflicts of interest None declared.

^¶

Plain language summary available online

Share a link

Email
Wechat
Bluesky

Summary

Background

Psychiatric disorders have been extensively documented in patients with systemic lupus erythematosus (SLE). However, the prevalence of psychiatric disorders in patients with skin-restricted lupus (SRL) remains unknown, although SRL is more common than SLE.

Objectives

To assess current and lifetime prevalence of Axis I psychiatric disorders among outpatients with SRL and to examine the factors associated with psychiatric disorders among such patients.

Methods

A multicentre case–control study involving outpatients with SRL and controls matched for sex, age and education level. The Mini International Neuropsychiatric Interview was used for psychiatric evaluation.

Results

We evaluated 75 patients and 150 controls. Of these, 49% of patients vs. 13% of controls fulfilled the criteria for at least one current psychiatric disorder (P < 0·001). The following disorders were significantly more frequent among patients than controls: current and lifetime major depressive disorder (9% vs. 0%, P < 0·001 and 44% vs. 26%, P = 0·01), generalized anxiety disorder (23% vs. 3%, P < 0·001 and 35% vs. 19%, P = 0·03), panic disorder (7% vs. 0%, P = 0·004 and 21% vs. 3%, P < 0·001), current suicide risk (24% vs. 7%, P = 0·003), alcohol dependence (7% vs. 0%, P = 0·004) and lifetime agoraphobia (20% vs. 9%, P = 0·01). Lupus duration and lupus past treatment by thalidomide were significantly higher among patients with current psychiatric disorders.

Conclusions

This study demonstrates a high prevalence of several psychiatric disorders (anxiety, depression, suicide risk, alcohol dependence) in patients with SRL.

Supporting Information

References

1Meszaros ZS, Perl A, Faraone SV. Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry 2012; 73: 993–1001.
10.4088/JCP.11r07425
PubMed Web of Science® Google Scholar
2Durosaro O, Davis MDP, Reed KB, Rohlinger AL. Incidence of cutaneous lupus erythematosus, 1965–2005: a population-based study. Arch Dermatol 2009; 145: 249–53.
10.1001/archdermatol.2009.21
PubMed Web of Science® Google Scholar
3Causse C, D'Incan M, Gerbaud L et al. Évaluation psychiatrique de patients atteints de lupus chronique et de lupus subaigu. Étude préliminaire. Ann Med Psychol (Paris) 2003; 161: 700–5 (in French).
10.1016/j.amp.2003.09.003
Google Scholar
4Albrecht J, Taylor L, Berlin JA et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005; 125: 889–94.
10.1111/j.0022-202X.2005.23889.x
CAS PubMed Web of Science® Google Scholar
5Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(Suppl. 20): 22–33.
PubMed Web of Science® Google Scholar
6Lecrubier Y, Sheehan DV, Weiller E et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 224–31.
10.1016/S0924-9338(97)83296-8
Web of Science® Google Scholar
7Lempérière T, Lépine JP, Rouillon F et al. Comparison of various tools for evaluating depression apropos of a study on Athymil 30 mg. Ann Med Psychol (Paris) 1984; 142: 1206–14 (in French).
CAS PubMed Web of Science® Google Scholar
8Lépine JP, Gasquet I, Kovess V et al. [Prevalence and comorbidity of psychiatric disorders in the French general population]. Encephale 2005; 31: 182–94 (in French).
10.1016/S0013-7006(05)82385-1
PubMed Web of Science® Google Scholar
9Alonso J, Angermeyer MC, Bernert S et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 109 (Suppl. S420): 21–7.
Google Scholar
10Cohen AD, Ofek-Shlomai A, Vardy DA et al. Depression in dermatological patients identified by the Mini International Neuropsychiatric Interview questionnaire. J Am Acad Dermatol 2006; 54: 94–9.
10.1016/j.jaad.2005.09.019
PubMed Web of Science® Google Scholar
11Jarpa E, Babul M, Calderón J et al. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus 2011; 20: 58–66.
10.1177/0961203310381773
CAS PubMed Web of Science® Google Scholar
12Uguz F, Kucuk A, Cicek E et al. Mood, anxiety and personality disorders in patients with systemic lupus erythematosus. Compr Psychiatry 2013; 54: 341–5.
10.1016/j.comppsych.2012.10.003
PubMed Web of Science® Google Scholar
13Nery FG, Borba EF, Viana VS et al. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 695–700.
10.1016/j.pnpbp.2007.11.014
CAS PubMed Web of Science® Google Scholar
14Brey RL, Holliday SL, Saklad AR et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58: 1214–20.
10.1212/WNL.58.8.1214
CAS PubMed Web of Science® Google Scholar
15Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010; 146: 891–5.
10.1001/archdermatol.2010.186
PubMed Web of Science® Google Scholar
16Picardi A, Lega I, Tarolla E. Suicide risk in skin disorders. Clin Dermatol 2013; 31: 47–56.
10.1016/j.clindermatol.2011.11.006
PubMed Web of Science® Google Scholar
17Mok CC, Chan KL, Cheung EF, Yip PS. Suicidal ideation in patients with systemic lupus erythematosus: incidence and risk factors. Rheumatology (Oxford) 2014; 53: 714–21.
10.1093/rheumatology/ket404
PubMed Web of Science® Google Scholar
18Xie LF, Chen PL, Pan HF et al. Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience. Rheumatol Int 2012; 32: 2707–14.
10.1007/s00296-011-2043-3
PubMed Web of Science® Google Scholar
19Bando DH, Brunoni AR, Fernandes TG et al. Suicide rates and trends in São Paulo, Brazil, according to gender, age and demographic aspects: a joinpoint regression analysis. Rev Bras Psiquiatr 2012; 34: 286–93.
10.1016/j.rbp.2012.02.001
PubMed Web of Science® Google Scholar
20Nicoli M, Bouchez S, Nieto I et al. [Prevalence and risk factors for suicide ideation, plans and attempts in the French general population: results from the ESEMeD study]. Encephale 2012; 38: 296–303 (in French).
10.1016/j.encep.2011.02.006
CAS PubMed Web of Science® Google Scholar
21Boeckler P, Cosnes A, Francès C et al. Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus. Arch Dermatol 2009; 145: 1012–16.
10.1001/archdermatol.2009.199
PubMed Web of Science® Google Scholar
22Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 2009; 61: 822–9.
10.1002/art.24519
PubMed Web of Science® Google Scholar
23Beck F, Guignard R. La dépression en France (2005-2010)?: prévalence, recours au soin et sentiment d'information de la population (in French). Available at: http://www.inpes.sante.fr/Barometres/barometre-sante-2010/pdf/SH-depression.pdf (last accessed 2 February 2016).
Google Scholar
24Briffault X, Morvan Y, Rouillon F et al. Use of services and treatment adequacy of major depressive episodes in France. Encephale 2010; 36 (Suppl. 2): D48–58 (in French).
10.1016/j.encep.2008.10.011
PubMed Web of Science® Google Scholar
25Chapireau F. Les recours aux soins spécialisés en santé mentale (in French). Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques - Ministère des Affaires sociales et de la Santé; 2006 Report No. 533. Available at: http://www.drees.sante.gouv.fr/etudes-et-statistiques/publications/etudes-et-resultats/article/les-recours-aux-soins-specialises-en-sante-mentale (last accessed 2 February 2016).
Google Scholar
26Ng CY, Yang YW, Liu SH et al. SF-36 health survey on psoriasis quality-of-life: a study of 414 Taiwanese patients. J Dermatol 2015; 42: 159–65.
10.1111/1346-8138.12748
PubMed Web of Science® Google Scholar
27Sangma LN, Nath J, Bhagabati D. Quality of life and psychological morbidity in vitiligo patients: a study in a teaching hospital from north-East India. Indian J Dermatol 2015; 60: 142–6.
10.4103/0019-5154.152508
PubMed Web of Science® Google Scholar
28Boeckler P, Milea M, Meyer A et al. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency. Br J Dermatol 2005; 152: 265–70.
10.1111/j.1365-2133.2004.06308.x
CAS PubMed Web of Science® Google Scholar
29Gallego H, Crutchfield CE 3rd, Lewis EJ, Gallego HJ. Report of an association between discoid lupus erythematosus and smoking. Cutis 1999; 63: 231–4.
CAS PubMed Web of Science® Google Scholar
30Metelitsa AI, Lauzon GJ. Tobacco and the skin. Clin Dermatol 2010; 28: 384–90.
10.1016/j.clindermatol.2010.03.021
PubMed Web of Science® Google Scholar
31Miot HA, Bartoli Miot LD, Haddad GR. Association between discoid lupus erythematosus and cigarette smoking. Dermatology 2005; 211: 118–22.
10.1159/000086440
PubMed Web of Science® Google Scholar
32Lasser K, Boyd JW, Woolhandler S et al. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606–10.
10.1001/jama.284.20.2606
CAS PubMed Web of Science® Google Scholar
33Eyre HA, Stuart MJ, Baune BT. A phase-specific neuroimmune model of clinical depression. Prog Neuropsychopharmacol Biol Psychiatry 2014; 54: 265–74.
10.1016/j.pnpbp.2014.06.011
CAS PubMed Web of Science® Google Scholar
34Furtado M, Katzman MA. Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Res 2015; 229: 37–48.
10.1016/j.psychres.2015.05.036
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume174, Issue5

May 2016

Pages 1051-1060

High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case–control study^†

Summary

Background

Objectives

Methods

Results

Conclusions

Supporting Information

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case–control study†

Summary

Background

Objectives

Methods

Results

Conclusions

Supporting Information

References

Citing Literature

References

Related

Information

High prevalence of psychiatric disorders in patients with skin-restricted lupus: a case–control study^†